Tag

letters – access to medicines
March 29, 2023ByIn

Letter to President von der Leyen: Delayed publication of the EU pharmaceutical legislation revision

2023-03-29_Letter-to-President-von-der-Leyen_EU-pharmaceutical-legislation-revision
Continue Reading
March 16, 2023ByIn

Letter: Cancer patients need a patient-centred and fit for purpose pharmaceutical system

2023-03-16_ECL-Anticancer-Fund-EFPN-letter-to-the-European-Commission_Revision-of-the-EU-pharmaceuticals-legislation-1
Continue Reading
March 9, 2023ByIn

Letter: Publish the proposed revision of the EU pharmaceutical legislation NOW

2023-03_09_Joint-letter_Publish-the-proposed-revision-of-the-EU-pharmaceutical-legislation-NOW
Continue Reading
February 22, 2022ByIn

Letter: Prevention of medicine shortages through the constitution of safety stocks

Joint-Letter_med_shortages_safety_stocks_EC
Continue Reading
May 17, 2019ByIn

Letter: Request to start an investigation into the factors leading to medicines shortages

Drug-Shortages-Letter_EC_170519
Continue Reading
May 17, 2019ByIn

Letter: Supporting the Italian draft resolution on improving the transparency of markets for medicines and vaccines

ECL-Support-for-Italian-draft-resolution_72WHA
Continue Reading
December 18, 2018ByIn,

How the European Medicines Agency engages with medicine producers before they apply for authorisations

ECL-Comments-European-Ombudsman-EMA-inquiry-Dec-2018
Continue Reading
February 2, 2017ByIn

Letter: European collaboration on equal access to cancer medicines and the role of EU competition policy

6_Open-letter-Commissioner-Vestager-Access-to-Medicines-final-sent
Continue Reading